Emi An

666 total citations
23 papers, 491 citations indexed

About

Emi An is a scholar working on Hematology, Immunology and Emergency Medicine. According to data from OpenAlex, Emi An has authored 23 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 8 papers in Immunology and 5 papers in Emergency Medicine. Recurrent topics in Emi An's work include Acute Myeloid Leukemia Research (16 papers), Immune Cell Function and Interaction (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Emi An is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Immune Cell Function and Interaction (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Emi An collaborates with scholars based in Japan. Emi An's co-authors include Kíyoyuki Ogata, Norio Yokose, Kyoko Nakamura, Takeo Nomura, Kazuo Dan, K Dan, Hideto Tamura, Yumiko Shioi, Y Onozawa and Toshiharu Ito and has published in prestigious journals such as British Journal of Cancer, Stem Cells and British Journal of Haematology.

In The Last Decade

Emi An

23 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emi An Japan	12	240	159	60	58	46	23	491
Katja Garimorth Austria	9	71 0.3×	140 0.9×	31 0.5×	107 1.8×	74 1.6×	10	513
Rune Larsen Denmark	13	68 0.3×	92 0.6×	27 0.5×	74 1.3×	32 0.7×	29	514
Graham Briars United Kingdom	10	114 0.5×	54 0.3×	33 0.6×	120 2.1×	123 2.7×	15	567
Monika Cymer Poland	10	148 0.6×	65 0.4×	18 0.3×	195 3.4×	25 0.5×	15	426
Marcello Corsi Italy	10	73 0.3×	18 0.1×	48 0.8×	42 0.7×	38 0.8×	41	366
D Rieu France	13	131 0.5×	32 0.2×	143 2.4×	69 1.2×	9 0.2×	60	709
Zhenggang Luan China	10	82 0.3×	12 0.1×	63 1.1×	106 1.8×	21 0.5×	15	402
Tryggve Ljung Sweden	11	83 0.3×	18 0.1×	100 1.7×	71 1.2×	33 0.7×	16	428
Chiara Gioia Italy	11	79 0.3×	28 0.2×	47 0.8×	90 1.6×	32 0.7×	22	460
Boram Cha South Korea	12	53 0.2×	24 0.2×	36 0.6×	211 3.6×	58 1.3×	47	462

Countries citing papers authored by Emi An

Since Specialization

Citations

This map shows the geographic impact of Emi An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi An more than expected).

Fields of papers citing papers by Emi An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi An. The network helps show where Emi An may publish in the future.

Co-authorship network of co-authors of Emi An

This figure shows the co-authorship network connecting the top 25 collaborators of Emi An. A scholar is included among the top collaborators of Emi An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi An. Emi An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ogata, Kíyoyuki, Emi An, Yumiko Shioi, et al.. (2001). Association between natural killer cell activity and infection in immunologically normal elderly people. Clinical & Experimental Immunology. 124(3). 392–397. 143 indexed citations

Nakamura, Kyoko, Kíyoyuki Ogata, Emi An, & Kazuo Dan. (2000). Flow cytometric assessment of CD15+CD117+ cells for the detection of minimal residual disease in adult acute myeloid leukaemia. British Journal of Haematology. 108(4). 710–716. 17 indexed citations

An, Emi, et al.. (2000). Low proportion of G0-phase cells during induction chemotherapy correlates with subsequent remission in acute myeloid leukemia.. PubMed. 71(3). 249–55. 6 indexed citations

Yokose, Norio, Kíyoyuki Ogata, Hideto Tamura, et al.. (1998). Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma. British Journal of Cancer. 77(12). 2286–2290. 25 indexed citations

Tamura, Hideto, Kíyoyuki Ogata, Shigeki Mori, et al.. (1998). Lymphoblastic lymphoma of natural killer cell origin, presenting as pancreatic tumour. Histopathology. 32(6). 508–511. 11 indexed citations

Ogata, Kíyoyuki, Emi An, Norio Yokose, et al.. (1998). Repeated Cycles of G‐CSF‐Combined Postremission Chemotherapy for Acute Myeloid Leukemia in a First Complete Remission: A Pilot Study. Stem Cells. 16(4). 280–287. 2 indexed citations

Hasegawa, Setsuo, Kazutaka Nakayama, Katsuhiko Iwakiri, et al.. (1997). Herbal Medicine-Associated Lead Intoxication.. Internal Medicine. 36(1). 56–58. 13 indexed citations

Tamura, H., Sha Luo, Emi An, et al.. (1997). 94 Plasma thrombopoietin (TPO) level in patients with myelodysplastic syndromes (MDS). Leukemia Research. 21(1). S25–S25. 1 indexed citations

Ogata, Kíyoyuki, Norio Yokose, Hideto Tamura, et al.. (1997). Natural Killer Cells in the Late Decades of Human Life. Clinical Immunology and Immunopathology. 84(3). 269–275. 114 indexed citations

10.

Tamura, Hideki, et al.. (1996). Autoimmune hemolytic anemia in patients with de novo acute myelocytic leukemia. Annals of Hematology. 72(1). 45–47. 1 indexed citations

11.

Ogata, Kíyoyuki, Norio Yokose, Emi An, et al.. (1996). Plasma soluble interleukin‐2 receptor level in patients with primary myelodysplastic syndromes: a relationship with disease subtype and clinical outcome. British Journal of Haematology. 93(1). 45–52. 18 indexed citations

12.

Yokose, Norio, Kíyoyuki Ogata, Emi An, et al.. (1995). Lineage-unrestricted hematologic response to granulocyte colony-stimulating factor in a patient with refractory anemia with excess blasts. Annals of Hematology. 70(3). 163–167. 3 indexed citations

13.

Ogata, Kíyoyuki, Norio Yokose, Emi An, et al.. (1995). Effects of interleukin‐12 on natural killer cell cytotoxicity and the production of interferon‐7 and tumour necrosis factor‐a in patients with myelodysplastic syndromes. British Journal of Haematology. 90(1). 15–21. 19 indexed citations

14.

Ogata, Kíyoyuki, Norio Yokose, Toshiharu Ito, et al.. (1994). Assessment of therapeutic potential of interleukin 2 for myelodysplastic syndromes. British Journal of Haematology. 86(3). 562–567. 9 indexed citations

15.

Yokose, Norio, Kíyoyuki Ogata, Toshiharu Ito, et al.. (1994). Elevated plasma soluble interleukin 2 receptor level correlates with defective natural killer and CD8+ T-cells in myelodysplastic syndromes. Leukemia Research. 18(10). 777–782. 14 indexed citations

16.

Ogata, Kíyoyuki, Norio Yokose, Toshiharu Ito, et al.. (1993). Effects of interleukin 2 on myelodysplastic syndromes. Leukemia Research. 17(2). 137–142. 7 indexed citations

17.

Yokose, Norio, Kíyoyuki Ogata, Toshiharu Ito, et al.. (1993). Chemotherapy for minimally differentiated acute myeloid leukemia (AML-M0). Annals of Hematology. 66(2). 67–70. 23 indexed citations

18.

An, Emi, Makoto Futaki, Koichi Inokuchi, et al.. (1993). Megakaryocyte, Erythroid and Granulocyte-Macrophage Colony Formation in Myelodysplastic Syndromes. Acta Haematologica. 89(3). 113–118. 20 indexed citations

19.

Ito, Toshiharu, K Suyama, Norio Yokose, et al.. (1993). [Two cases of acute leukemia with t(6;9) (p23;q34)].. PubMed. 34(1). 50–6. 2 indexed citations

20.

Dan, Kazuo, et al.. (1991). Cell‐mediated cyclic thrombocytopenia treated with azathioprine. British Journal of Haematology. 77(3). 365–370. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact